5% de descuento en todos los libros solicitados por la web
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy

Table of contents (5 chapters)
Melanoma Immunotherapy

Gregory A. Daniels MD, PhD

Pages
Combinatorial Checkpoint Blockade Immunotherapy and Radiation

Sangwoo Shawn Kim, Andrew Sharabi

Pages
Cellular Therapy

Aaron M. Goodman MD, Tiffany N. Tanaka MD, Dan S. Kaufman MD, PhD

Pages
Pharmacokinetics and Pharmacodynamics of Immunotherapy

Lisa H. Lam PharmD, Swan D. Lin PharmD, Ji Sun PharmD, PhD

Pages
Immune Checkpoint Combinations with Inflammatory Pathway Modulators

N. DeVito, et al.

Pages
ISBN
978-3-319-63756-3
EAN
9783319637563
Editor
Springer Verlag Gmbh&Co. Kg
Stock
NO
Idioma
Inglés
Nivel
Profesional
Formato
Encuadernado
Tapa Dura
Páginas
331
Largo
-
Ancho
-
Peso
-
Edición
Fecha de edición
16-02-2018
Año de edición
2018
Nº de ediciones
1
Colección
Current Cancer Research
Nº de colección
-